Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Net Asset Momentum
Hubei Jumpcan Pharmaceutical Co Ltd (600566) recorded a net asset momentum of 10.2% as of December 2024, with net assets of CN¥14.73 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Hubei Jumpcan Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hubei Jumpcan Pharmaceutical Co Ltd Net Asset Momentum (1998–2024)
This chart tracks Hubei Jumpcan Pharmaceutical Co Ltd's year-over-year net asset growth across 27 annual reporting periods from 1998 to 2024. The most recent momentum reading is +10.2%, with net assets of CN¥14.73 Billion CNY as of December 2024. Read Hubei Jumpcan Pharmaceutical Co Ltd (600566) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hubei Jumpcan Pharmaceutical Co Ltd (1998–2024)
The table below shows the complete annual net asset history for Hubei Jumpcan Pharmaceutical Co Ltd from 1998 to 2024, covering 27 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Hubei Jumpcan Pharmaceutical Co Ltd worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥14.73 Billion | CN¥18.46 Billion | CN¥3.73 Billion | ▲ +10.2% |
| 2023 | CN¥13.37 Billion | CN¥18.14 Billion | CN¥4.77 Billion | ▲ +17.8% |
| 2022 | CN¥11.35 Billion | CN¥14.98 Billion | CN¥3.63 Billion | ▲ +24.3% |
| 2021 | CN¥9.13 Billion | CN¥12.13 Billion | CN¥3.00 Billion | ▲ +17.6% |
| 2020 | CN¥7.76 Billion | CN¥10.52 Billion | CN¥2.75 Billion | ▲ +27.2% |
| 2019 | CN¥6.10 Billion | CN¥8.66 Billion | CN¥2.56 Billion | ▲ +11.8% |
| 2018 | CN¥5.46 Billion | CN¥7.80 Billion | CN¥2.34 Billion | ▲ +24.0% |
| 2017 | CN¥4.40 Billion | CN¥6.66 Billion | CN¥2.26 Billion | ▲ +19.4% |
| 2016 | CN¥3.69 Billion | CN¥4.99 Billion | CN¥1.30 Billion | ▲ +35.9% |
| 2015 | CN¥2.71 Billion | CN¥3.59 Billion | CN¥872.59 Million | ▲ +18.3% |
| 2014 | CN¥2.29 Billion | CN¥3.36 Billion | CN¥1.06 Billion | ▲ +99.1% |
| 2013 | CN¥1.15 Billion | CN¥2.01 Billion | CN¥862.04 Million | ▲ +134.8% |
| 2012 | CN¥490.80 Million | CN¥992.87 Million | CN¥502.07 Million | ▼ -6.8% |
| 2011 | CN¥526.82 Million | CN¥961.82 Million | CN¥435.00 Million | ▲ +1.3% |
| 2010 | CN¥520.27 Million | CN¥863.16 Million | CN¥342.89 Million | ▲ +1.4% |
| 2009 | CN¥512.85 Million | CN¥836.22 Million | CN¥323.37 Million | ▲ +1.3% |
| 2008 | CN¥506.18 Million | CN¥829.61 Million | CN¥323.43 Million | ▲ +1.5% |
| 2007 | CN¥498.83 Million | CN¥802.32 Million | CN¥303.49 Million | ▲ +2.7% |
| 2006 | CN¥485.82 Million | CN¥786.51 Million | CN¥300.69 Million | ▲ +1.2% |
| 2005 | CN¥480.25 Million | CN¥732.21 Million | CN¥251.96 Million | ▲ +1.3% |
| 2004 | CN¥473.92 Million | CN¥697.90 Million | CN¥223.98 Million | ▲ +1.6% |
| 2003 | CN¥466.47 Million | CN¥650.39 Million | CN¥183.92 Million | ▲ +1.6% |
| 2002 | CN¥459.05 Million | CN¥607.22 Million | CN¥148.17 Million | ▲ +2.1% |
| 2001 | CN¥449.57 Million | CN¥582.65 Million | CN¥133.08 Million | ▲ +221.1% |
| 2000 | CN¥140.01 Million | CN¥223.38 Million | CN¥83.37 Million | ▲ +11.6% |
| 1999 | CN¥125.46 Million | CN¥196.69 Million | CN¥71.23 Million | ▲ +15.7% |
| 1998 | CN¥108.44 Million | CN¥186.23 Million | CN¥77.79 Million | — |